Why Dropsuite, Monadelphous, Sigma, and Telix shares are storming higher today

These shares are starting the week on a positive note. But why?

| More on:
a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 200 Index (ASX: XJO) has fought back from a poor start and is pushing higher. In early afternoon trade, the benchmark index is up 0.2% to 8,425.7 points.

Four ASX shares that are rising more than most today are listed below. Here's why they are climbing:

Dropsuite Ltd (ASX: DSE)

The Dropsuite share price is up 30% to $5.70. Investors have been buying this cloud software platform provider's shares after it received and accepted a takeover offer. Dropsuite has entered into a scheme implementation deed with NinjaOne, under which it will be acquired for $5.90 per share in cash. The Dropsuite board unanimously recommends that shareholders vote in favour of the scheme. This is in the absence of a superior proposal and subject to an independent expert report. Non-Executive Chairman, Theo Hnarakis, said: "While the Board is highly confident in the long-term fundamentals and growth prospects of the Company, we believe the Scheme represents a compelling opportunity for shareholders to realise their investment in Dropsuite, for 100% cash at an attractive premium to where Dropsuite has historically traded."

Monadelphous Group Ltd (ASX: MND)

The Monadelphous share price is up 3.5% to $15.41. This may have been driven by a broker note out of Macquarie. According to the note, the broker has upgraded the engineering company's shares to an outperform rating with an improved price target of $15.93. Macquarie notes that the company's profit guidance for the first half was well ahead of its estimates thanks to better than expected margins.

Sigma Healthcare Ltd (ASX: SIG)

The Sigma Healthcare share price is up 8% to $2.92. This follows the release of a trading update for the Chemist Warehouse business. Sigma is aiming to merge with Chemist Warehouse next month. According to the release, Chemist Warehouse delivered a 13% increase in first half sales to $5,154 million and 36.1% jump in profit before tax to $436.8 million. The company opened 19 new stores in the half with two new stores opening in Dubai. It notes that this is "a new geography with attractive opportunities."

Telix Pharmaceuticals Ltd (ASX: TLX)

The Telix Pharmaceuticals share price is up 5.5% to $29.03. This morning, this radiopharmaceuticals company announced the completion of the acquisition of RLS (USA). It is the United States' only Joint Commission-accredited radiopharmacy network distributing PET, SPECT, and therapeutic radiopharmaceuticals. Management notes that the "acquisition immediately enhances Telix's presence in the United States, with a network of over 30 radiopharmacies dispensing radiopharmaceuticals manufactured by Telix and other companies."

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the 'five best ASX stocks' for investors to buy right now. We believe these stocks are trading at attractive prices and Scott thinks they could be great buys right now...

See The 5 Stocks *Returns as of 30 April 2025

Motley Fool contributor James Mickleboro has positions in Telix Pharmaceuticals. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group and Telix Pharmaceuticals. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

The silhouettes of ten people holding hands with their arms raised against the sky, as the sun rises or sets in the background.
Share Gainers

Here are the top 10 ASX 200 shares today

ASX shares finished the trading week on a high this Friday.

Read more »

A businessman stacks building blocks.
Technology Shares

6% gain! What's up with Block shares today?

Block shares are up more than 34% since 2 May.

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Share Gainers

Why ARB, Block, Mayne Pharma, and Paladin Energy shares are charging higher today

These shares are having a strong finish to the week. But why?

Read more »

A woman puts her hands up as she smashes and breaks through a glass ceiling.
Share Gainers

How these 5 ASX 200 stocks are smashing the benchmark this week

These fives ASX 200 stocks have made some very happy shareholders this week. Here’s how.

Read more »

A man looking at his laptop and thinking.
Share Gainers

Here are the top 10 ASX 200 shares today

The markets lost their steam this Thursday.

Read more »

Ecstatic woman looking at her phone outside with her fist pumped.
Share Gainers

Why Catapult, Hutchinson, SKS, and West African shares are pushing higher today

These shares are having a strong session despite the market weakness.

Read more »

Rising gold share price represented by a green arrow on piles of gold block.
Gold

Up 72% in 2025, why is this ASX 200 gold stock racing ahead of the benchmark again today?

Investors are bidding up this high-flying ASX 200 gold stock again on Thursday. But why?

Read more »

Businessman smiles with arms outstretched after receiving good news.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a wonderful Wednesday session for investors today.

Read more »